26 completed, 7 terminated. 33 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 33 | Completed 26, Terminated 7 |
| Phase 2 | 6 | Completed 5, Terminated 1 |
Follow Recurrent Rectal Cancer: new trials by email Literature Review of Recurrent Rectal Cancer trials Research Report on Recurrent Rectal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver irinotecan-eluting beads, hepatic artery embolization - Liver Metastases, Mucinous Adenocarcinoma of the Colon | Phase 1 | Terminated | Fox Chase Cancer Center | 2 | 2016-01-29 | 2018-02-26 |
| CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery 6,8-bis(benzylthio)octanoic acid, fluorouracil, pharmacological study - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 1 | Completed | Wake Forest University Health Sciences | 19 | 2015-01-06 | 2023-08-07 |
| Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer intensity-modulated radiation therapy, fluorouracil, oxaliplatin - Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer | Phase 1 | Completed | Virginia Commonwealth University | 14 | 2014-12-04 | 2021-07-20 |
| MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer MEK inhibitor MEK162, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Completed | City of Hope Medical Center | 26 | 2014-07-16 | 2026-10-19 |
| Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer irinotecan hydrochloride, alisertib - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 1 | Completed | University of California, Davis | 17 | 2013-08-01 | 2019-01-04 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy 18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 / Phase 2 | Completed | Sanjiv Sam Gambhir | 25 | 2013-03-04 | 2019-10-03 |
| Ipilimumab and Local Radiation for Selected Solid Tumors Ipilimumab, Radiation therapy - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Terminated | Stanford University | 3 | 2013-02-01 | 2024-01-24 |
| Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer trametinib, fluorouracil, radiation therapy - Recurrent Rectal Cancer, Stage IIA Rectal Cancer | Phase 1 | Completed | Ohio State University Comprehensive Cancer Center | 19 | 2012-11-26 | 2023-09-18 |
| Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors selumetinib, cetuximab, laboratory biomarker analysis - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 33 | 2012-10-01 | 2014-05-29 |
| Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer laboratory biomarker analysis, enzyme-linked immunosorbent assay, flow cytometry - Recurrent Colon Cancer, Recurrent Gastric Cancer | Phase 1 | Completed | City of Hope Medical Center | 12 | 2011-12-22 | 2026-10-19 |
| Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer irinotecan hydrochloride, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Completed | City of Hope Medical Center | 3 | 2011-08-30 | 2026-10-16 |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer AUY922, Cetuximab - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Completed | Swedish Medical Center | 20 | 2011-02-01 | 2015-06-08 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors veliparib, capecitabine, oxaliplatin - Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach | Phase 1 | Terminated | National Cancer Institute (NCI) | 16 | 2010-10-01 | 2014-04-02 |
| Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Terminated | University of Southern California | 7 | 2010-10-01 | 2015-05-27 |
| Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer irinotecan-eluting beads, hepatic artery embolization - Liver Metastases, Mucinous Adenocarcinoma of the Colon | Phase 1 | Terminated | Fox Chase Cancer Center | 4 | 2010-10-01 | 2021-12-20 |
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors gamma-secretase/Notch signalling pathway inhibitor RO4929097, capecitabine, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2010-06-01 | 2014-11-07 |
| Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer pertuzumab, cetuximab, irinotecan hydrochloride - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2007-10-01 | 2015-03-31 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer cetuximab, erlotinib hydrochloride, laboratory biomarker analysis - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 1 | Completed | National Cancer Institute (NCI) | 43 | 2007-01-01 | 2015-09-30 |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors oxaliplatin, leucovorin calcium, vorinostat - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 54 | 2005-07-01 | 2013-09-30 |
| Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery gemcitabine hydrochloride, floxuridine, proteomic profiling - Liver Metastases, Recurrent Colon Cancer | Phase 1 / Phase 2 | Completed | City of Hope Medical Center | 16 | 2005-06-13 | 2026-11-03 |
Showing 20 of 33. Sign in to see all of them.
Rectal Neoplasms (33) · Colonic Neoplasms (31) · Pancreatic Neoplasms (10) · Carcinoma, Non-Small-Cell Lung (8) · Breast Neoplasms (7) · Salivary Gland Neoplasms (7) · Stomach Neoplasms (6) · Breast Neoplasms, Male (5) · Carcinoma, Hepatocellular (5) · Esthesioneuroblastoma, Olfactory (5) · Squamous Cell Carcinoma of Head and Neck (5) · Anus Neoplasms (4) · Carcinoma, Ovarian Epithelial (4) · Esophageal Neoplasms (4) · Gallbladder Neoplasms (4)
Digestive System Diseases (32) · Digestive System Neoplasms (32) · Gastrointestinal Diseases (32) · Intestinal Diseases (32) · Intestinal Neoplasms (32) · Neoplasms by Site (32) · Rectal Diseases (32) · Gastrointestinal Neoplasms (31) · Neoplasms (31) · Colonic Diseases (30) · Colorectal Neoplasms (30) · Endocrine Gland Neoplasms (10) · Endocrine System Diseases (10) · Neoplasms by Histologic Type (10) · Pancreatic Diseases (10)
Fluorouracil (9) · Cetuximab (6) · Irinotecan (6) · Leucovorin (6) · Oxaliplatin (6) · Erlotinib Hydrochloride (4) · Bevacizumab (3) · Capecitabine (3) · Gene Expression Profiling (2) · Granulocyte-Macrophage Colony-Stimulating Factor (2) · Radiation (2) · Radiotherapy (2) · sargramostim (2) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · 2C4 antibody (1)
National Cancer Institute (NCI) (19) · City of Hope Medical Center (4) · Fox Chase Cancer Center (2) · Ohio State University Comprehensive Cancer Center (1) · Sanjiv Sam Gambhir (1) · Stanford University (1) · Swedish Medical Center (1) · University of California, Davis (1) · University of Southern California (1) · Virginia Commonwealth University (1) · Wake Forest University Health Sciences (1)
United States (33) · Canada (1)
Marwan Fakih (2) · Wells Messersmith (2) · William Schelman (2) · Alain Mita (1) · Antonius Miller (1) · Caio Rocha Lima, MD (1) · Efrat Dotan (1) · Efrat Dotan, MD (1) · Emma C Fields, MD (1) · George A. Fisher, MD, PhD (1) · Heinz-Josef Lenz (1) · James Abbruzzese (1) · Jeffrey Wong (1) · Jeffrey Wong, MD (1) · John Marshall (1)
PMID 24987057, PMID 25965900, PMID 26062933, PMID 26611425, PMID 30850872, PMID 33993383
P30CA014520 (3), U01CA062491 (3), U01CA070095 (2), N01CM17003 (1), P30CA006927 (1), P30CA012197 (1), P30CA016059 (1), P30CA044579 (1), P30CA051008 (1), P30CA054174 (1), P30CA068485 (1), P30CA093373 (1), R01CA088972 (1), R21CA117125 (1), U01CA062490 (1)